Peishu Liu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
Papers in
-
- Circular RNAs in diseases 7
- Cancer-related gene regulation 7
- RNA Interference and Gene Delivery 5
-
- MicroRNA in disease regulation 11
- Cancer-related molecular mechanisms research 8
- Co-authors
- Xinrui Zhao (8 shared papers)Yingxin Pang (16 shared papers)Hongluan Mao (14 shared papers)Jing Xue (6 shared papers)Lidong Liu (4 shared papers)Rui Li (6 shared papers)Liang Shen (4 shared papers)Congcong Ma (3 shared papers)
- Journals
- Archives of Gynecology and Obstetrics (8 papers)OncoTargets and Therapy (5 papers)Oncology Reports (3 papers)Cancer Management and Research (3 papers)Medicine (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Peishu Liu
59 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 91
- Cancer Research 473
- Reproductive Medicine 116
- Molecular Biology 774
- Molecular Medicine 47
- Obstetrics and Gynecology 73
Countries citing papers authored by Peishu Liu
This map shows the geographic impact of Peishu Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peishu Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peishu Liu more than expected).
Fields of papers citing papers by Peishu Liu
This network shows the impact of papers produced by Peishu Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peishu Liu. The network helps show where Peishu Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Peishu Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 95 | |
| 2 | 2019 | 67 | |
| 3 | Autophagy inhibition promotes epithelial-mesenchymal transition through ROS/HO-1 pathway in ovarian cancer cells. | 2016 | 61 |
| 4 | 2014 | 50 | |
| 5 | 2015 | 47 | |
| 6 | 2021 | 47 | |
| 7 | 2018 | 47 | |
| 8 | Silibinin restores paclitaxel sensitivity to paclitaxel-resistant human ovarian carcinoma cells. | 2008 | 46 |
| 9 | 2018 | 46 | |
| 10 | 2012 | 44 | |
| 11 | Survivin expression in ovarian cancer. | 2007 | 41 |
| 12 | 2014 | 40 | |
| 13 | 2017 | 39 | |
| 14 | 2017 | 35 | |
| 15 | 2019 | 31 | |
| 16 | 2019 | 30 | |
| 17 | 2013 | 25 | |
| 18 | 2017 | 23 | |
| 19 | 2019 | 22 | |
| 20 | 2014 | 22 |
About Peishu Liu
Peishu Liu is a scholar working on Molecular Biology, Cancer Research, Oncology, Surgery and Obstetrics and Gynecology, having authored 62 papers that have together received 1.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (8 papers), Circular RNAs in diseases (7 papers), Cancer-related gene regulation (7 papers), Endometrial and Cervical Cancer Treatments (6 papers), Pelvic floor disorders treatments (6 papers), RNA Interference and Gene Delivery (5 papers) and Ovarian cancer diagnosis and treatment (5 papers). The work is most often cited by research in Cancer Research (473 citations), Reproductive Medicine (116 citations), Molecular Biology (774 citations), Molecular Medicine (47 citations) and Obstetrics and Gynecology (73 citations). Peishu Liu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Xinrui Zhao, Yingxin Pang, Hongluan Mao, Jing Xue, Lidong Liu, Rui Li, Liang Shen, Congcong Ma, Yu Wang and Xin Lv. Their work appears in journals such as Archives of Gynecology and Obstetrics, OncoTargets and Therapy, Oncology Reports, Cancer Management and Research and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.